DTx Podcast with Eugene Borukhovich

As an engineer, Melinda Decker could have designed widgets or Styrofoam cups or even gone into winemaking. But her passion for improving patient outcomes led her to digital therapeutics, and eventually to Mymee, a direct-to-consumer platform that helps people with autoimmune disorders manage their symptoms.Mymee recognizes that behavior change is hard, so they combine a user-friendly app and data analytics with health coaching, to help users identify their triggers and make long-lasting lifestyle changes that lessen the severity of their symptoms and improve their overall health. Since its founding in 2017, Mymee has collaborated on two publications and recently closed a funding round of $8.7 million.Join Eugene and Melinda’s conversation about digital therapeutics vs. disease management and the path the Mymee team took to getting their solution off the ground.>>Click here to read the transcriptGuest Links and Resources: Connect with Melinda Decker: LinkedIn Visit Mymee: Twitter | LinkedIn | Facebook | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

When Peter Hames struggled with insomnia, he couldn’t get access to any treatment other than sleeping pills. Out of “desperation,” he said, Peter self-administered a cognitive behavioral therapy (CBT) course and within weeks was sleeping like a baby. That experience led to the development of Sleepio, an app which uses artificial intelligence to deliver digital cognitive behavioral therapy to improve user's sleep. IPeter applied his background in experimental psychology and technology to co-found Big Health, a digital therapeutics (DTx) company whose mission is to “help millions back to good mental health.” With 53 peer-reviewed papers and 13 randomized control trials, Big Health is also one of the only DTx companies in the world with an evidence base of its size, rigor, and quality.Join Eugene and Peter as they talk about the early days of digital therapeutics, Big Health’s unique direct-to-consumer approach in the UK and the US, and its deep-rooted commitment to clinical evidence and supporting science.May 20, 2022 News Update: National Institute for Health and Care Excellence recommends the use of Sleepio for treatment of insomnia when compared to pills or other methods Read more on the Telegraph: Trouble sleeping? Doctors will prescribe an app now instead of pills>>Click here to read the transcriptGuest Links and Resources: Connect with Peter Hames: LinkedIn Visit Big Health: Twitter | LinkedIn | Website Learn more about Sleepio Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

There are two kinds of people in the world, says Brent Vaughan — those who prefer to make incremental changes with a lower likelihood of failure, and those who aspire to fix (seemingly) intractable problems that have stymied others. Brent falls in the latter category. A serial entrepreneur, former venture capitalist, and current CEO of Cognito Therapeutics (a DTx company that specializes in neurodegenerative diseases), Brent is also uniquely positioned to evaluate the future of next generation digital therapeutics.Brent and Eugene talk about the differences between prescription and business-to-consumer DTx, the importance of engaging patients and users early on in the development of novel products, and the exciting potential of translational DTx solutions. Eugene’s podcast partner, Brian Dolan, also pops in with a question.>>Click here to read the transcriptGuest Links and Resources: Connect with Brent Vaughan: LinkedIn Visit Cognito Therapeutics: Twitter | LinkedIn | Facebook | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In this episode, I speak with Ed Cox, who is an Executive Vice President of Strategic Alliances and Global Head of Digital Medicines at EVERSANA. In our conversation, we focus on his journey through Dthera and the many lessons learned. But before we dive in: Those of you who know Ed, will agree, he is a memorable guy, and therefore I am super surprised I can not even remember where we first met but what I do know is that every time I speak with Ed, I feel like I have known him my whole life.  >>Click here to read the transcriptBe sure to check out my previous episode where I spoke with David Klein, CEO and Founder of Click Therapeutics - a company that was started in 2012 as a smoking cessation app and now with a pipeline of DTx therapies and a $500M deal with Boehringer Ingelheim. Guest Links and Resources: Connect with Edward Cox: LinkedIn Visit EVERSANA : Twitter | LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In the last episode, I had the pleasure of speaking with Eddie Martucci, CEO and Founder of Akili Interactive - the creators of EndeavourRx, which is the first and only prescription treatment delivered through a video game. Imagine that!In this episode, I continue my DTx journey with yet another early trailblazer, David Klein, CEO and co-founder of Click Therapeutics.I first met David at Frontiers Health conference a few years back. He struck me as cool and composed, with a clear vision. Tune in as David shares a little bit of his background and how did he come to starting Click Therapeutics back in the day.>>Click here to read the transcriptGuest Links and Resources: Connect with David Klein: LinkedIn Visit Click Therapeutics: Twitter | LinkedIn | Facebook | Instagram | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

On the last episode, I got to know Anand Iyer, Chief Strategy Officer at WellDoc, who was instrumental in getting the Digital Therapeutics Alliance up and running. In this episode, the focus on the early trailblazers of the DTx industry continues with Eddie Martucci. Eddie is the CEO and founder of Akili Interactive, which has taken a super interesting go to market approach.I very briefly met Eddie, at a small event during the JPMorgan conference in San Francisco years ago. Eddie's energy and passion for the product exuded while he was showing a crowd of onlookers an early version of a game that is now an actual digital therapy, EndeavorRxClick here to read the transcriptGuest Links and Resources: Connect with Eddie Martucci: Twitter | LinkedIn Visit Akili Interactive Labs Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In this episode, Eugene Borukhovich interviews Anand Iyer, Chief Strategy Officer of Welldoc, discussing the early days of Welldoc and the digital therapeutics industry. They talk about leveraging mobile platforms for personalized coaching, obtaining FDA clearance, demystifying digital therapeutics, potential exit strategies for digital health companies, and the transformative power of digital therapeutics in improving lives.

In this episode, we speak with one of the founding members of the Digital Therapeutics Alliance ('DTA'), Pierre Leurent. Pierre is the CEO and founder of Voluntis, which is the first publicly listed DTx company on Euronext in Paris.Pierre co-founded Voluntis in 2001 with the mission to improve patients’ experience with their treatment thanks to digital technologies. Now, 20 years later, they have supported more than 600,000 patients and deployed over 50 programs around the world.Pierre is a Director of the Digital Therapeutics Alliance, of which he served as Chairman, and a member of Advamed’s Digital Health Executive Leadership Group. He previously co-chaired the digital therapeutics task force of the Personal Connected Health Alliance, a member of HIMSS, and chaired the eHealth France Alliance regrouping several leading trade organizations representing digital and life sciences companies in France. Pierre holds a MS from Ecole Centrale Paris.Links and Resources: Connect with Pierre Leurent: Twitter | LinkedIn Visit Voluntis Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In the previous episode in this two-part deep dive inside the Digital Therapeutics Alliance, I spoke to Megan Coder, the Executive Director for the DTA. In this episode, I'm excited to chat with Jessica Shull, European lead for the DTA. I met Jessica and Sitges, Spain near Barcelona at a HIMSS EU Health 2.0 event. Jessica struck me as sharp, composed and super knowledgeable, and of course, a great addition to the DTA. With Jessica's leadership, the DTA expanded its coverage across Europe, LATAM and Australia.Click here to read the transcriptLinks and Resources: Connect with Jessica Shull: Twitter | LinkedIn Visit the Digital Therapeutics Alliance Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In the previous episode, Brian Dolan and I discussed the definition of digital therapeutics. The term 'digital therapeutics' has been used since about 2012, and in 2017 the Digital Therapeutics Alliance, aka DTA, came on the scene.In this two-part deep dive we go inside the DTA and in this episode, we start with Megan Coder, the Executive Director.I remember meeting the energetic, polished, and absolutely no BS, Megan, at the 2017 Frontiers Health in Berlin - yes, when face-to-face conferences were still a thing. At that conference, the DTA was officially launched. I strongly believe this was a historic moment for the overall industry.Click here to read the transcriptLinks and Resources: Connect with Megan Coder: Twitter Visit the Digital Therapeutics Alliance Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter HealthXL: Website | Twitter | Join an Event Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche